[18]F-PSMA-1007
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [18]F-PSMA-1007, covering 2025-06-12 to 2025-06-12. Get the full timeline:
Most recent: Clinical Trial Update: A Study of [18]F-PSMA-1007 in Patients With Known or Suspected Metastatic Prostate Cancer [Phase 2]